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Vitamin D deﬁciency is a well-known comorbidity of obesity that can be exacerbated after bariatric surgery and can predispose
the patient for hypocalcemia. Vitamin D and calcium doses to prevent and treat vitamin D deﬁciency after weight loss surgery are
not well deﬁned. We describe a patient who developed severe hypocalcemia due to vitamin D deﬁciency 5 years after an extended
Roux-en-Y gastric bypass for a type II obesity. No precipitating factors were present and malabsorption induced by the bypass
was considered to be the main causative factor. High doses of vitamin D and calcium were needed to reach and maintain normal
calciumandvitaminDconcentrations.ThiscaseemphasisestheimportanceofroutinescreeningforvitaminDdeﬁciencyin obese
individuals and reﬂects that while consensus does not exist regarding optimal dosage, vitamin D replacement should be tittered
based on calcidiol levels.
1.Introduction
Hypovitaminosis D and secondary hyperparathyroidism are
associated with morbid obesity. In contrast with many
obesity-related comorbid conditions, this vitamin D deﬁ-
ciency is not corrected by obesity surgery and may even
be exacerbated, especially when the obesity surgery involves
malabsorption [1, 2]. We report a patient who underwent a
Roux-en-Y gastric bypass (RYGB) and who later developed
severe, symptomatic hypocalcemia due to severe vitamin D
deﬁciency.
2.CaseReport
A 69-year-old woman was referred to our hospital with
severe hypocalcemia detected during routine analyses for
anemia.
Five years earlier she had had a RYGB (common channel
80cmlengthandRouxlimb250cmlength)inanothercentre
as treatment for type II obesity associated to type 2 diabetes
mellitus and hypertension. No postsurgical follow-up was
performed.
After surgery, her body mass index decreased from
37Kg/m2 to 24Kg/m2 and her diabetes remitted. She began
to pass 4-5 stools per day and her primary care doctor
diagnosed an iron deﬁciency anemia refractory to oral
supplements.
Four months before she was ﬁrst visited at our centre,
she began to experience general weakness, muscle pain,
and cramps. Her family doctor performed an ambulatory
densitometry which showed a bone pattern compatible with
osteomalacia. Perioral paraesthesias appeared some weeks
later but she denied tetania or hand cramping.
At ﬁrst visit at our centre she was taking irbesartan, iron,
and potassium supplements and a multivitamin complex
containing 500IU of cholecalciferol and 125mg of calcium,
all prescribed in the previous months by her family doctor.
The patient did not smoke nor drink.
Physical examination revealed positive Chvostek’s and
Trousseau’s signs. Serum total calcium was 1.47mmol/L
(normal range 2,15–2,55mmol/L), serum phosphate was
1.21mmol/L (normal range0,87–1,45mmol/L),serumcrea-
tinine was 82 was µmol/L (normal <80µmol/L), and alkaline
phosphatase was 239U/L (normal range 35–110U/L) with2 Journal of Obesity
normal levels of AST, ALT, and GGT. Calcidiol level was
19.6nmol/L (normal range 80–275nmol/L) and parathyroid
hormone (PTH) level was 9.1pmol/L (normal range 1.3–1.8
pmol/L). We prescribed 1500mg/day calcium carbonate and
16,000IU of 25-hydroxivitamin D per week.
Four days later, the patient required hospitalization
as symptoms did not improve and blood tests showed
persistent hypocalcemia with calcium levels of 1.37nmol/L.
Oral calcium intake was increased to 3gr per day and
25-hydroxyvitamin D was prescribed every 48 hours. A
calcium gluconate infusion was started. We also admin-
istered 1500mg of oral magnesium as serum levels were
0.65mmol/L (normal range 0.65–1.05mmol/L). Hypocal-
cemic symptoms improved over the next 2-3 days but the
calcium gluconate infusion was required for a further 7 days
before calcium levels became stable with oral supplementa-
tion alone. At discharge, ten days after admission, her serum
calcium level was 1.86mmol/L and she was taking calcium
carbonate 3gr per day, 25-hydroxivitamin D 16,000IU per
day and magnesium sulphate 1,500mg per day.
At follow-up, one month later, calcidiol and PTH had
reached 123nmol/L and 14.7pmol/L, respectively, calcium
level was 1.64mmol/L and the patient was asymptomatic.
Medications were titrated to calcium carbonate 3000mg per
day, 25-hydroxyvitamin D 16.000IU every 72 hours, and
magnesium sulphate 1000mg per day. At ﬁve-month follow-
up on this regimen, the patient was stable with a serum
calcium of 2.16mmol/L.
3.Discussion
This case report illustrates the risk of severe hypocalcemia
and vitamin D deﬁciency following RYGB and the need for
high doses of calcium and vitamin D to prevent and treat
these deﬁciencies.
The risk of hypocalcemia in patients submitted to RYGB
may be explained by two mechanisms, the ﬁrst related to
calcium absorption. Calcium is mainly absorbed in the duo-
denumbutwhenaRYGBisperformed itisabsorbedthrough
alesseﬃcientmechanism inthedistalsmallbowel.Thisleads
to a certain degree of calcium malabsorption, especially if
diet calcium content is low. The second mechanism involves
fat soluble vitamin malabsorption due to impaired mixing
with bilesalts. It causes a vitamin D deﬁciency which further
impairs calcium absorption, thereby increasing the risk for
hypocalcemia [3–5].
Despite the changes in calcium and vitamin D
metabolism induced by RYGB, few cases of hypocalcemia
have been reported, and all of them have presented with a
precipitating factor such as thyroidectomy with secondary
hypoparathyroidism [6]. We did not ﬁnd any precipitating
factor in our patient. One possible explanation may be the
presence of a long Roux limb (250cm), which in contrast
with the standard technique, bypasses a greater part of the
small bowel. Extended bypasses have proven to be more
eﬀective in terms of weight loss in individuals with BMI >
50Kg/m2 and, although their eﬀects on calcium metabolism
have not been well documented, it is plausible that the
greater malabsorption they produce may increase the risk
for hypocalcemia [7].
Taking into account the frequency of vitamin D deﬁ-
ciency after RYGB, most practitioners routinely prescribe
vitamin D and calcium supplements after bariatric surgery.
Current recommended doses are 400–800IU of cholecal-
ciferol and 500–2000mg of calcium per day, [8–10]. In
our patient, vitamin D and calcium supplements were not
prescribed until several years after surgery, and the dose
prescribed was clearly insuﬃcient to prevent vitamin D
deﬁciency. Furthermore, the calcium 1500mg per day and
25-hydroxivitamin D 16.000IU per week that we prescribed
at ﬁrst visit at our centre failed to control hypocalcemia.
An infusion of calcium gluconate was needed over seven
days until oral regimens were eﬀective in controlling these
deﬁciencies. Our case reﬂects the diﬃculty in ﬁnding the
appropriatedoseofvitaminDandcalciumneededtoprevent
and treat vitamin D deﬁciency following bariatric surgery. It
also shows that high doses are oftennecessary toachievenor-
mal vitamin D and calcium levels. Doses of 5000IU per day
have been found to be safe and necessary in many patients
following RYGB [11]. Nevertheless, when malabsorption is
suspected, as in the case of extended by-passes, doses as
high as 50,000IU of cholecalciferol per day can be safely
administered [8, 9]. In our patient, high doses were required
to maintain an adequate vitamin D status, so 16,000IU of
25-hydroxivitamin D every 72h were maintained during
follow-up and could not be reduced. Taking into account
that 25-hydroxivitamin D is considered to have a biological
potency 10 times higher than cholecalciferol, our patient
ﬁnally needed the equivalent of 53,000IU of cholecalciferol
per day [12].
In conclusion, vitamin D deﬁciency is frequent in
the setting of RYGB and can cause severe hypocalcemia.
Screening for this comorbidityis therefore essential and high
dosesofvitaminDandcalciummaybeneeded.Asthereisno
consensus regarding optimal dosage, vitamin D replacement
should be titered based on calcidiol levels.
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